Steve Cohen: portfolio of Point72 Asset Management
Steve Cohen leads Point72, the successor to SAC Capital; the portfolio holds a very large number of positions and changes often.
Source: 13F filing with the US Securities and Exchange Commission dated Nov 14, 2023. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q3 2023. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 28.9B USD
- Positions
- 1,673
- Share of the ten largest
- 13.7%
The ten largest positions Q3 2023
- Nvidia 2.5%▲ +0.2%
- Microsoft 2.2%▲ +11.1%
- Amazon 1.9%▲ +38.5%
- Meta Platforms 1.4%▲ +62.8%
- Boston Scientific 1.2%▲ +84.0%
- Arista Networks 1.1%▲ +211.3%
- Neurocrine Biosciences Inc 1.0%▲ +2,215.2%
- BP (ADR) 0.8%▲ +79.9%
- Boeing 0.8%▲ +586.8%
- Dell Technologies 0.8%▼ −22.6%
Show all positions of this quarter
Choose a quarter (50 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
All positions Q3 2023
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| DELL Dell Technologies | 0.8% | 3,374,523 | 232.5M USD | −22.6% reduced | Q3 2022 5 quarters |
| TMUS T-Mobile US | 0.7% | 1,441,822 | 201.9M USD | −43.8% reduced | Q2 2020 14 quarters |
| Pioneer Nat Res Co | 0.6% | 807,904 | 185.5M USD | −4.0% reduced | Q4 2022 4 quarters |
| FDX FedEx | 0.6% | 646,636 | 171.3M USD | −13.2% reduced | Q1 2021 11 quarters |
| UNP Union Pacific Corporation | 0.6% | 833,378 | 169.7M USD | −1.3% reduced | Q2 2023 2 quarters |
| Marathon Oil Corp | 0.5% | 5,646,112 | 151.0M USD | −4.9% reduced | Q1 2021 11 quarters |
| WMT Walmart | 0.5% | 904,325 | 144.6M USD | −20.7% reduced | Q1 2023 3 quarters |
| Lamb Weston HLDGS Inc | 0.5% | 1,478,876 | 136.7M USD | −14.9% reduced | Q1 2022 7 quarters |
| Cenovus Energy Inc | 0.5% | 6,438,290 | 134.1M USD | −24.2% reduced | Q3 2022 5 quarters |
| TSM Taiwan Semiconductor Manufacturing (ADR) | 0.4% | 1,401,000 | 121.7M USD | −25.2% reduced | Q3 2021 9 quarters |
| Encompass Health Corp | 0.4% | 1,750,078 | 117.5M USD | −1.5% reduced | Q3 2022 5 quarters |
| Stoneco Ltd | 0.4% | 10,237,882 | 109.2M USD | −6.0% reduced | Q4 2021 8 quarters |
| COF Capital One | 0.4% | 1,096,734 | 106.4M USD | −19.7% reduced | Q1 2023 3 quarters |
| MSI Motorola Solutions | 0.4% | 380,913 | 103.7M USD | −36.9% reduced | Q1 2021 11 quarters |
| ZBH Zimmer Biomet | 0.3% | 890,377 | 99.9M USD | −45.6% reduced | Q1 2022 7 quarters |
| TDY Teledyne Technologies | 0.3% | 240,856 | 98.4M USD | −24.1% reduced | Q3 2020 13 quarters |
| LULU Lululemon Athletica | 0.3% | 252,490 | 97.4M USD | −15.4% reduced | Q2 2022 6 quarters |
| CB Chubb Limited | 0.3% | 462,378 | 96.3M USD | −21.5% reduced | Q2 2020 14 quarters |
| ISRG Intuitive Surgical | 0.3% | 264,826 | 77.4M USD | −52.8% reduced | Q4 2022 4 quarters |
| BABA Alibaba Group (ADR) | 0.3% | 879,563 | 76.3M USD | −8.5% reduced | Q4 2021 8 quarters |
| Academy Sports & Outdoors In | 0.3% | 1,529,653 | 72.3M USD | −13.2% reduced | Q2 2021 10 quarters |
| GPN Global Payments | 0.2% | 619,079 | 71.4M USD | −46.8% reduced | Q3 2018 21 quarters |
| RVTY Revvity | 0.2% | 641,403 | 71.0M USD | −46.1% reduced | Q4 2022 4 quarters |
| Molson Coors Beverage Co | 0.2% | 1,088,705 | 69.2M USD | −3.9% reduced | Q2 2023 2 quarters |
| Carlisle Cos Inc | 0.2% | 258,324 | 67.0M USD | −43.8% reduced | Q1 2022 7 quarters |
| XYL Xylem Inc. | 0.2% | 726,078 | 66.1M USD | −6.1% reduced | Q2 2022 6 quarters |
| Nutanix Inc | 0.2% | 1,891,387 | 66.0M USD | −26.5% reduced | Q2 2022 6 quarters |
| FLEX Flex Ltd. | 0.2% | 2,375,118 | 64.1M USD | −6.0% reduced | Q1 2022 7 quarters |
| T AT&T | 0.2% | 4,115,900 | 61.8M USD | −51.7% reduced | Q1 2023 3 quarters |
| Burlington Stores Inc | 0.2% | 445,741 | 60.3M USD | −11.4% reduced | Q1 2023 3 quarters |
| 10X Genomics Inc | 0.2% | 1,347,419 | 55.6M USD | −16.0% reduced | Q1 2023 3 quarters |
| TRGP Targa Resources | 0.2% | 643,871 | 55.2M USD | −43.2% reduced | Q3 2019 17 quarters |
| Owens Corning New | 0.2% | 404,509 | 55.2M USD | −42.8% reduced | Q2 2023 2 quarters |
| Cameco Corp | 0.2% | 1,340,822 | 53.2M USD | −13.2% reduced | Q1 2021 11 quarters |
| Stmicroelectronics N V | 0.2% | 1,226,663 | 52.9M USD | −45.2% reduced | Q3 2022 5 quarters |
| Webster Finl Corp | 0.2% | 1,292,762 | 52.1M USD | −31.6% reduced | Q1 2022 7 quarters |
| RTX RTX Corporation | 0.2% | 714,787 | 51.4M USD | −3.0% reduced | Q3 2022 5 quarters |
| Imperial Oil Ltd | 0.2% | 826,319 | 51.0M USD | −25.8% reduced | Q4 2022 4 quarters |
| Icon PLC | 0.2% | 204,134 | 50.3M USD | −62.0% reduced | Q3 2022 5 quarters |
| Unum Group | 0.2% | 1,008,004 | 49.6M USD | −13.7% reduced | Q1 2022 7 quarters |
| PM Philip Morris International | 0.2% | 535,110 | 49.5M USD | −28.4% reduced | Q4 2022 4 quarters |
| Radnet Inc | 0.2% | 1,703,811 | 48.0M USD | −17.5% reduced | Q2 2020 14 quarters |
| EMR Emerson Electric | 0.2% | 486,540 | 47.0M USD | −44.1% reduced | Q1 2023 3 quarters |
| MDT Medtronic | 0.2% | 589,062 | 46.2M USD | −43.9% reduced | Q4 2022 4 quarters |
| HAS Hasbro | 0.2% | 685,697 | 45.4M USD | −38.8% reduced | Q4 2022 4 quarters |
| Tenet Healthcare Corp | 0.2% | 686,824 | 45.3M USD | −16.4% reduced | Q4 2022 4 quarters |
| Louisiana Pac Corp | 0.2% | 808,745 | 44.7M USD | −8.3% reduced | Q2 2023 2 quarters |
| VMC Vulcan Materials Company | 0.2% | 216,273 | 43.7M USD | −44.8% reduced | Q1 2021 11 quarters |
| APP AppLovin | 0.1% | 1,074,539 | 42.9M USD | −18.4% reduced | Q2 2023 2 quarters |
| Fluor Corp New | 0.1% | 1,169,902 | 42.9M USD | −12.3% reduced | Q2 2022 6 quarters |
| V Visa Inc. | 0.1% | 182,641 | 42.0M USD | −34.4% reduced | Q3 2020 13 quarters |
| MAT Mattel | 0.1% | 1,906,107 | 42.0M USD | −59.6% reduced | Q3 2020 13 quarters |
| EXC Exelon | 0.1% | 1,092,859 | 41.3M USD | −28.9% reduced | Q3 2022 5 quarters |
| Glaukos Corp | 0.1% | 533,339 | 40.1M USD | −20.4% reduced | Q4 2021 8 quarters |
| FIS Fidelity National Information Services | 0.1% | 720,675 | 39.8M USD | −68.7% reduced | Q1 2019 19 quarters |
| MRSH Marsh McLennan | 0.1% | 198,707 | 37.8M USD | −41.0% reduced | Q2 2021 10 quarters |
| Sarepta Therapeutics Inc | 0.1% | 307,343 | 37.3M USD | −6.7% reduced | Q1 2021 11 quarters |
| MU Micron Technology | 0.1% | 542,049 | 36.9M USD | −80.8% reduced | Q2 2023 2 quarters |
| Cogent Biosciences Inc | 0.1% | 3,766,755 | 36.7M USD | −19.6% reduced | Q1 2023 3 quarters |
| Advanced Drain Sys Inc Del | 0.1% | 318,638 | 36.3M USD | −28.0% reduced | Q2 2023 2 quarters |
| VST Vistra Corp. | 0.1% | 1,091,504 | 36.2M USD | −40.2% reduced | Q1 2021 11 quarters |
| O-I Glass Inc | 0.1% | 2,062,261 | 34.5M USD | −3.9% reduced | Q3 2022 5 quarters |
| Ambarella Inc | 0.1% | 644,814 | 34.2M USD | −51.7% reduced | Q3 2021 9 quarters |
| AZO AutoZone | 0.1% | 12,963 | 32.9M USD | −88.0% reduced | Q1 2020 15 quarters |
| Regal Rexnord Corporation | 0.1% | 227,180 | 32.5M USD | −8.2% reduced | Q3 2022 5 quarters |
| East West Bancorp Inc | 0.1% | 610,380 | 32.2M USD | −59.2% reduced | Q1 2022 7 quarters |
| LHX L3Harris | 0.1% | 182,775 | 31.8M USD | −21.9% reduced | Q4 2022 4 quarters |
| Western Alliance Bancorp | 0.1% | 691,400 | 31.8M USD | −42.7% reduced | Q1 2021 11 quarters |
| TTWO Take-Two Interactive | 0.1% | 220,500 | 31.0M USD | −85.0% reduced | Q3 2021 9 quarters |
| ADBE Adobe Inc. | 0.1% | 60,578 | 30.9M USD | −92.0% reduced | Q3 2022 5 quarters |
| Coupang Inc | 0.1% | 1,794,697 | 30.5M USD | −7.9% reduced | Q4 2022 4 quarters |
| Pulmonx Corp | 0.1% | 2,929,903 | 30.3M USD | −11.9% reduced | Q4 2020 12 quarters |
| HSIC Henry Schein | 0.1% | 407,410 | 30.3M USD | −8.9% reduced | Q2 2023 2 quarters |
| Abcam PLC | 0.1% | 1,330,000 | 30.1M USD | −83.2% reduced | Q3 2022 5 quarters |
| VRTX Vertex Pharmaceuticals | 0.1% | 85,414 | 29.7M USD | −65.3% reduced | Q3 2022 5 quarters |
| Equity Residential | 0.1% | 494,907 | 29.1M USD | −17.2% reduced | Q4 2021 8 quarters |
| HLT Hilton Worldwide | < 0.1% | 191,527 | 28.8M USD | −46.4% reduced | Q4 2021 8 quarters |
| SHOP Shopify | < 0.1% | 505,064 | 27.6M USD | −67.2% reduced | Q1 2023 3 quarters |
| Biohaven Ltd | < 0.1% | 1,025,495 | 26.7M USD | −12.4% reduced | Q3 2022 5 quarters |
| Etsy Inc | < 0.1% | 412,848 | 26.7M USD | −30.9% reduced | Q2 2023 2 quarters |
| MRK Merck & Co. | < 0.1% | 258,352 | 26.6M USD | −60.9% reduced | Q2 2020 14 quarters |
| Jack In The Box Inc | < 0.1% | 381,208 | 26.3M USD | −44.4% reduced | Q3 2022 5 quarters |
| Murphy Oil Corp | < 0.1% | 572,862 | 26.0M USD | −59.2% reduced | Q4 2022 4 quarters |
| Performance Food Group Co | < 0.1% | 427,599 | 25.2M USD | −30.0% reduced | Q2 2019 18 quarters |
| Exact Sciences Corp | < 0.1% | 367,451 | 25.1M USD | −69.1% reduced | Q3 2022 5 quarters |
| Gfl Environmental Inc | < 0.1% | 769,943 | 24.5M USD | −48.0% reduced | Q2 2023 2 quarters |
| Sensata Technologies Hldg Pl | < 0.1% | 644,293 | 24.4M USD | −20.0% reduced | Q2 2023 2 quarters |
| Trex Co Inc | < 0.1% | 380,197 | 23.4M USD | −71.7% reduced | Q4 2022 4 quarters |
| NRG NRG Energy | < 0.1% | 598,195 | 23.0M USD | −17.2% reduced | Q4 2022 4 quarters |
| Activision Blizzard Inc | < 0.1% | 243,657 | 22.8M USD | −46.9% reduced | Q2 2023 2 quarters |
| DKNG DraftKings | < 0.1% | 759,860 | 22.4M USD | −59.4% reduced | Q1 2022 7 quarters |
| Coty Inc | < 0.1% | 2,037,626 | 22.4M USD | −14.7% reduced | Q2 2023 2 quarters |
| Brp Group Inc | < 0.1% | 961,686 | 22.3M USD | −8.0% reduced | Q3 2021 9 quarters |
| Heico Corp New | < 0.1% | 172,431 | 22.3M USD | −21.5% reduced | Q1 2023 3 quarters |
| Griffon Corp | < 0.1% | 555,933 | 22.1M USD | −2.8% reduced | Q1 2023 3 quarters |
| Rh | < 0.1% | 83,207 | 22.0M USD | −67.4% reduced | Q1 2023 3 quarters |
| FIVE9 Inc | < 0.1% | 341,800 | 22.0M USD | −58.2% reduced | Q4 2021 8 quarters |
| Pacific Biosciences Calif In | < 0.1% | 2,593,782 | 21.7M USD | −61.1% reduced | Q3 2022 5 quarters |
| Warner Bros Discovery Inc | < 0.1% | 1,899,339 | 20.6M USD | −34.8% reduced | Q4 2022 4 quarters |
| WYNN Wynn Resorts | < 0.1% | 217,390 | 20.1M USD | −80.6% reduced | Q3 2022 5 quarters |
| Agenus Inc | < 0.1% | 17,615,811 | 19.9M USD | 0.0% reduced | Q2 2022 6 quarters |
| Biocryst Pharmaceuticals Inc | < 0.1% | 2,758,813 | 19.5M USD | −31.1% reduced | Q4 2022 4 quarters |
| Daqo New Energy Corp | < 0.1% | 631,776 | 19.1M USD | −9.7% reduced | Q1 2023 3 quarters |
| FITB Fifth Third Bancorp | < 0.1% | 748,931 | 19.0M USD | −25.6% reduced | Q2 2022 6 quarters |
| CFG Citizens Financial Group | < 0.1% | 707,187 | 19.0M USD | −18.5% reduced | Q2 2023 2 quarters |
| On Hldg AG | < 0.1% | 667,522 | 18.6M USD | −16.2% reduced | Q2 2023 2 quarters |
| Novartis AG | < 0.1% | 181,247 | 18.5M USD | −80.0% reduced | Q2 2022 6 quarters |
| RIVN Rivian Automotive | < 0.1% | 753,291 | 18.3M USD | −73.2% reduced | Q4 2022 4 quarters |
| Tripadvisor Inc | < 0.1% | 1,090,020 | 18.1M USD | −21.4% reduced | Q3 2022 5 quarters |
| Praxis Precision Medicines I | < 0.1% | 10,383,780 | 17.8M USD | −1.6% reduced | Q4 2020 12 quarters |
| Boise Cascade Co Del | < 0.1% | 172,073 | 17.7M USD | −34.6% reduced | Q1 2023 3 quarters |
| Comerica Inc | < 0.1% | 405,325 | 16.8M USD | −47.8% reduced | Q4 2021 8 quarters |
| DD DuPont | < 0.1% | 225,273 | 16.8M USD | −60.0% reduced | Q2 2019 18 quarters |
| Ally Finl Inc | < 0.1% | 629,171 | 16.8M USD | −51.5% reduced | Q1 2023 3 quarters |
| CI Cigna | < 0.1% | 57,710 | 16.5M USD | −90.3% reduced | Q4 2021 8 quarters |
| Treace Med Concepts Inc | < 0.1% | 1,252,628 | 16.4M USD | −11.7% reduced | Q4 2021 8 quarters |
| TER Teradyne | < 0.1% | 160,337 | 16.1M USD | −50.4% reduced | Q2 2023 2 quarters |
| LIN Linde plc | < 0.1% | 43,161 | 16.1M USD | −43.2% reduced | Q1 2023 3 quarters |
| Inari Med Inc | < 0.1% | 235,904 | 15.4M USD | −65.4% reduced | Q1 2023 3 quarters |
| CME CME Group | < 0.1% | 76,202 | 15.3M USD | −52.9% reduced | Q2 2014 or earlier 38 quarters |
| Copa Holdings SA | < 0.1% | 161,852 | 14.4M USD | −12.2% reduced | Q4 2022 4 quarters |
| Exelixis Inc | < 0.1% | 657,404 | 14.4M USD | −80.1% reduced | Q1 2020 15 quarters |
| Anaptysbio Inc | < 0.1% | 791,200 | 14.2M USD | −45.8% reduced | Q4 2021 8 quarters |
| Tricon Residential Inc | < 0.1% | 1,902,000 | 14.1M USD | −23.0% reduced | Q2 2023 2 quarters |
| Hudson Pac Pptys Inc | < 0.1% | 2,074,900 | 13.8M USD | −53.2% reduced | Q1 2023 3 quarters |
| Nvent Electric PLC | < 0.1% | 257,483 | 13.6M USD | −54.4% reduced | Q3 2022 5 quarters |
| Xpo Inc | < 0.1% | 182,102 | 13.6M USD | −82.9% reduced | Q2 2023 2 quarters |
| Sterling Infrastructure Inc | < 0.1% | 183,506 | 13.5M USD | −2.7% reduced | Q3 2022 5 quarters |
| Brinker Intl Inc | < 0.1% | 416,309 | 13.2M USD | −6.0% reduced | Q2 2023 2 quarters |
| HWM Howmet Aerospace | < 0.1% | 276,394 | 12.8M USD | −63.9% reduced | Q4 2020 12 quarters |
| Blue Owl Capital Inc | < 0.1% | 985,500 | 12.8M USD | −36.6% reduced | Q3 2022 5 quarters |
| Liberty Broadband Corp | < 0.1% | 139,400 | 12.7M USD | −35.0% reduced | Q4 2022 4 quarters |
| BIIB Biogen | < 0.1% | 48,100 | 12.4M USD | −92.3% reduced | Q3 2020 13 quarters |
| Civitas Resources Inc | < 0.1% | 152,396 | 12.3M USD | −0.2% reduced | Q2 2023 2 quarters |
| CRL Charles River Laboratories | < 0.1% | 61,586 | 12.1M USD | −75.9% reduced | Q2 2023 2 quarters |
| Chart Inds Inc | < 0.1% | 70,639 | 11.9M USD | −59.7% reduced | Q1 2023 3 quarters |
| Centessa Pharmaceuticals PLC | < 0.1% | 1,840,482 | 11.9M USD | −8.5% reduced | Q2 2021 10 quarters |
| Abercrombie & Fitch Co | < 0.1% | 204,453 | 11.5M USD | −72.0% reduced | Q2 2022 6 quarters |
| Amicus Therapeutics Inc | < 0.1% | 946,697 | 11.5M USD | −86.5% reduced | Q1 2023 3 quarters |
| Brixmor Ppty Group Inc | < 0.1% | 546,896 | 11.4M USD | −41.3% reduced | Q4 2021 8 quarters |
| BNY BNY Mellon | < 0.1% | 263,969 | 11.3M USD | −32.0% reduced | Q4 2022 4 quarters |
| CASY Casey's | < 0.1% | 41,281 | 11.2M USD | −84.8% reduced | Q4 2022 4 quarters |
| Enovix Corporation | < 0.1% | 875,174 | 11.0M USD | −27.3% reduced | Q3 2022 5 quarters |
| AVGO Broadcom | < 0.1% | 13,178 | 10.9M USD | −79.7% reduced | Q3 2021 9 quarters |
| Stag Indl Inc | < 0.1% | 312,486 | 10.8M USD | −10.7% reduced | Q4 2021 8 quarters |
| Equitrans Midstream Corp | < 0.1% | 1,138,676 | 10.7M USD | −44.4% reduced | Q2 2022 6 quarters |
| Stericycle Inc | < 0.1% | 238,134 | 10.6M USD | −46.6% reduced | Q1 2023 3 quarters |
| IFF International Flavors & Fragrances | < 0.1% | 155,914 | 10.6M USD | −23.0% reduced | Q1 2023 3 quarters |
| TSN Tyson Foods | < 0.1% | 209,000 | 10.6M USD | −58.2% reduced | Q1 2023 3 quarters |
| Crane Company | < 0.1% | 118,288 | 10.5M USD | −6.6% reduced | Q2 2023 2 quarters |
| Ishares TR | < 0.1% | 125,956 | 10.4M USD | −4.1% reduced | Q1 2022 7 quarters |
| CCL Carnival Corporation | < 0.1% | 755,722 | 10.4M USD | −36.5% reduced | Q1 2023 3 quarters |
| Empire St Rlty TR Inc | < 0.1% | 1,287,084 | 10.3M USD | −3.7% reduced | Q1 2023 3 quarters |
| West Fraser Timber Co Ltd | < 0.1% | 142,112 | 10.3M USD | −71.5% reduced | Q1 2023 3 quarters |
| Somalogic Inc | < 0.1% | 4,316,749 | 10.3M USD | −12.0% reduced | Q3 2021 9 quarters |
| Flowserve Corp | < 0.1% | 258,399 | 10.3M USD | −34.6% reduced | Q2 2023 2 quarters |
| Gritstone Bio Inc | < 0.1% | 5,924,867 | 10.2M USD | −21.8% reduced | Q4 2022 4 quarters |
| Veracyte Inc | < 0.1% | 441,987 | 9.9M USD | −60.5% reduced | Q2 2023 2 quarters |
| Technipfmc PLC | < 0.1% | 477,850 | 9.7M USD | −82.0% reduced | Q2 2023 2 quarters |
| Prosperity Bancshares Inc | < 0.1% | 175,205 | 9.6M USD | −21.0% reduced | Q1 2023 3 quarters |
| Axis Cap HLDGS Ltd | < 0.1% | 168,697 | 9.5M USD | −36.9% reduced | Q1 2023 3 quarters |
| Jinkosolar Hldg Co Ltd | < 0.1% | 303,055 | 9.2M USD | −13.6% reduced | Q4 2022 4 quarters |
| E L F Beauty Inc | < 0.1% | 83,600 | 9.2M USD | −18.9% reduced | Q4 2022 4 quarters |
| OSCR Oscar Health | < 0.1% | 1,608,530 | 9.0M USD | −52.9% reduced | Q4 2022 4 quarters |
| ETN Eaton Corporation | < 0.1% | 41,598 | 8.9M USD | −84.2% reduced | Q1 2023 3 quarters |
| Match Group Inc New | < 0.1% | 224,517 | 8.8M USD | −84.3% reduced | Q4 2021 8 quarters |
| Gitlab Inc | < 0.1% | 193,909 | 8.8M USD | −28.3% reduced | Q1 2023 3 quarters |
| Marinus Pharmaceuticals Inc | < 0.1% | 1,065,037 | 8.6M USD | −19.6% reduced | Q4 2022 4 quarters |
| Brookdale Sr Living Inc | < 0.1% | 1,972,400 | 8.2M USD | −41.9% reduced | Q1 2023 3 quarters |
| Pinterest Inc | < 0.1% | 297,885 | 8.1M USD | −66.5% reduced | Q2 2023 2 quarters |
| New Oriental Ed & Technology | < 0.1% | 135,500 | 7.9M USD | −40.3% reduced | Q4 2022 4 quarters |
| AXP American Express | < 0.1% | 52,943 | 7.9M USD | −27.3% reduced | Q1 2022 7 quarters |
| AXON Axon Enterprise | < 0.1% | 38,499 | 7.7M USD | −37.1% reduced | Q4 2022 4 quarters |
| Deciphera Pharmaceuticals In | < 0.1% | 598,078 | 7.6M USD | −3.4% reduced | Q1 2023 3 quarters |
| Landstar Sys Inc | < 0.1% | 41,800 | 7.4M USD | −47.8% reduced | Q3 2022 5 quarters |
| Select Sector SPDR TR | < 0.1% | 215,000 | 7.1M USD | −4.4% reduced | Q4 2016 28 quarters |
| Option Care Health Inc | < 0.1% | 215,940 | 7.0M USD | −74.1% reduced | Q3 2022 5 quarters |
| Lear Corp | < 0.1% | 50,526 | 6.8M USD | −82.8% reduced | Q1 2023 3 quarters |
| Premier Inc | < 0.1% | 314,290 | 6.8M USD | −87.0% reduced | Q2 2022 6 quarters |
| Surgery Partners Inc | < 0.1% | 226,989 | 6.6M USD | −86.0% reduced | Q3 2021 9 quarters |
| Healthcare Rlty TR | < 0.1% | 433,100 | 6.6M USD | −42.5% reduced | Q3 2022 5 quarters |
| Alaska Air Group Inc | < 0.1% | 177,500 | 6.6M USD | −91.8% reduced | Q2 2018 22 quarters |
| Jefferies Finl Group Inc | < 0.1% | 177,217 | 6.5M USD | −82.4% reduced | Q1 2023 3 quarters |
| IOVA Iovance Biotherapeutics | < 0.1% | 1,412,550 | 6.4M USD | −81.9% reduced | Q1 2023 3 quarters |
| Ionis Pharmaceuticals Inc | < 0.1% | 141,500 | 6.4M USD | −30.8% reduced | Q1 2023 3 quarters |
| BAC Bank of America | < 0.1% | 231,570 | 6.3M USD | −73.2% reduced | Q2 2023 2 quarters |
| Plug Power Inc | < 0.1% | 829,216 | 6.3M USD | −70.0% reduced | Q1 2023 3 quarters |
| Gallagher Arthur J & Co | < 0.1% | 26,525 | 6.0M USD | −89.7% reduced | Q2 2021 10 quarters |
| Galapagos NV | < 0.1% | 173,300 | 6.0M USD | −80.3% reduced | Q3 2022 5 quarters |
| Vermilion Energy Inc | < 0.1% | 387,390 | 5.7M USD | −50.3% reduced | Q1 2022 7 quarters |
| Wisdomtree Inc | < 0.1% | 794,509 | 5.6M USD | −23.7% reduced | Q2 2023 2 quarters |
| Stevanato Group S P A | < 0.1% | 182,448 | 5.4M USD | −66.7% reduced | Q1 2023 3 quarters |
| Point Biopharma Global Inc | < 0.1% | 789,100 | 5.3M USD | −59.1% reduced | Q1 2022 7 quarters |
| Cal Maine Foods Inc | < 0.1% | 105,000 | 5.1M USD | −18.9% reduced | Q2 2022 6 quarters |
| Wd 40 Co | < 0.1% | 23,906 | 4.9M USD | −12.4% reduced | Q2 2023 2 quarters |
| Alector Inc | < 0.1% | 738,782 | 4.8M USD | −57.3% reduced | Q1 2023 3 quarters |
| Keros Therapeutics Inc | < 0.1% | 149,733 | 4.8M USD | −57.2% reduced | Q3 2022 5 quarters |
| Adtalem Global Ed Inc | < 0.1% | 111,251 | 4.8M USD | −21.5% reduced | Q2 2023 2 quarters |
| Ishares TR | < 0.1% | 125,000 | 4.7M USD | 0.0% reduced | Q2 2022 6 quarters |
| Reynolds Consumer Prods Inc | < 0.1% | 179,600 | 4.6M USD | −6.5% reduced | Q4 2022 4 quarters |
| Aclaris Therapeutics Inc | < 0.1% | 662,529 | 4.5M USD | −61.8% reduced | Q1 2021 11 quarters |
| Merus N V | < 0.1% | 183,394 | 4.3M USD | −69.9% reduced | Q1 2023 3 quarters |
| SPDR S&P 500 ETF TR | < 0.1% | 10,000 | 4.3M USD | −50.0% reduced | Q1 2022 7 quarters |
| Ati Inc | < 0.1% | 103,100 | 4.2M USD | −71.7% reduced | Q3 2022 5 quarters |
| TEL TE Connectivity | < 0.1% | 34,172 | 4.2M USD | −87.4% reduced | Q2 2023 2 quarters |
| EOSE Eos Energy Enterprises | < 0.1% | 1,926,633 | 4.1M USD | −26.7% reduced | Q3 2022 5 quarters |
| Excelerate Energy Inc | < 0.1% | 237,989 | 4.1M USD | −0.2% reduced | Q1 2023 3 quarters |
| Disc Medicine Inc | < 0.1% | 86,000 | 4.0M USD | −31.3% reduced | Q2 2023 2 quarters |
| Digitalbridge Group Inc | < 0.1% | 209,300 | 3.7M USD | −51.3% reduced | Q2 2023 2 quarters |
| Transalta Corp | < 0.1% | 407,300 | 3.6M USD | −32.4% reduced | Q3 2020 13 quarters |
| Talkspace Inc | < 0.1% | 1,790,000 | 3.5M USD | −7.0% reduced | Q2 2022 6 quarters |
| Gentex Corp | < 0.1% | 106,698 | 3.5M USD | −25.8% reduced | Q1 2023 3 quarters |
| Envista Holdings Corporation | < 0.1% | 124,306 | 3.5M USD | −32.5% reduced | Q3 2022 5 quarters |
| Carpenter Technology Corp | < 0.1% | 50,725 | 3.4M USD | −2.5% reduced | Q1 2023 3 quarters |
| Levi Strauss & Co New | < 0.1% | 250,339 | 3.4M USD | −47.1% reduced | Q2 2023 2 quarters |
| Augmedix Inc | < 0.1% | 650,000 | 3.3M USD | −65.5% reduced | Q2 2023 2 quarters |
| Lpl Finl HLDGS Inc | < 0.1% | 13,800 | 3.3M USD | −76.2% reduced | Q4 2022 4 quarters |
| Sony Group Corp | < 0.1% | 39,486 | 3.3M USD | −96.8% reduced | Q2 2022 6 quarters |
| HBAN Huntington Bancshares | < 0.1% | 312,383 | 3.2M USD | −85.0% reduced | Q4 2022 4 quarters |
| Black Diamond Therapeutics I | < 0.1% | 1,115,000 | 3.2M USD | −44.3% reduced | Q2 2023 2 quarters |
| Playtika Hldg Corp | < 0.1% | 328,149 | 3.2M USD | −76.9% reduced | Q2 2023 2 quarters |
| Matador Res Co | < 0.1% | 51,316 | 3.1M USD | −91.2% reduced | Q1 2023 3 quarters |
| Skyward Specialty Ins Group | < 0.1% | 111,360 | 3.0M USD | −66.6% reduced | Q1 2023 3 quarters |
| Esperion Therapeutics Inc Ne | < 0.1% | 3,097,852 | 3.0M USD | −37.7% reduced | Q2 2022 6 quarters |
| Tiptree Inc | < 0.1% | 170,420 | 2.9M USD | −32.8% reduced | Q4 2021 8 quarters |
| Clean Energy Fuels Corp | < 0.1% | 729,298 | 2.8M USD | −44.2% reduced | Q1 2022 7 quarters |
| Western Un Co | < 0.1% | 208,000 | 2.7M USD | −64.6% reduced | Q1 2023 3 quarters |
| Atlas Energy Solutions Inc | < 0.1% | 122,600 | 2.7M USD | −39.2% reduced | Q1 2023 3 quarters |
| Apple Hospitality REIT Inc | < 0.1% | 171,700 | 2.6M USD | −71.7% reduced | Q2 2022 6 quarters |
| LVS Las Vegas Sands | < 0.1% | 57,132 | 2.6M USD | −97.6% reduced | Q3 2018 21 quarters |
| CELH Celsius Holdings | < 0.1% | 14,218 | 2.4M USD | −35.1% reduced | Q4 2022 4 quarters |
| Angiodynamics Inc | < 0.1% | 325,641 | 2.4M USD | −25.3% reduced | Q4 2020 12 quarters |
| Si-Bone Inc | < 0.1% | 112,034 | 2.4M USD | −61.4% reduced | Q2 2023 2 quarters |
| VTRS Viatris | < 0.1% | 228,313 | 2.3M USD | −93.0% reduced | Q2 2023 2 quarters |
| Himax Technologies Inc | < 0.1% | 384,200 | 2.2M USD | −67.9% reduced | Q4 2022 4 quarters |
| Affimed N V | < 0.1% | 4,225,820 | 2.0M USD | −0.4% reduced | Q3 2019 17 quarters |
| Cousins Pptys Inc | < 0.1% | 97,428 | 2.0M USD | −66.9% reduced | Q1 2023 3 quarters |
| Opko Health Inc | < 0.1% | 1,221,700 | 2.0M USD | −20.6% reduced | Q1 2023 3 quarters |
| Zymeworks Inc | < 0.1% | 295,114 | 1.9M USD | −19.8% reduced | Q4 2022 4 quarters |
| Iqiyi Inc | < 0.1% | 389,428 | 1.8M USD | −71.3% reduced | Q2 2023 2 quarters |
| Guardant Health Inc | < 0.1% | 60,879 | 1.8M USD | −97.8% reduced | Q2 2023 2 quarters |
| Larimar Therapeutics Inc | < 0.1% | 455,000 | 1.8M USD | −45.8% reduced | Q3 2022 5 quarters |
| Wolverine World Wide Inc | < 0.1% | 221,700 | 1.8M USD | −51.7% reduced | Q1 2023 3 quarters |
| OPEN Opendoor Technologies | < 0.1% | 663,556 | 1.8M USD | −81.8% reduced | Q3 2021 9 quarters |
| Fleetcor Technologies Inc | < 0.1% | 6,200 | 1.6M USD | −88.5% reduced | Q1 2023 3 quarters |
| Rayonier Inc | < 0.1% | 54,922 | 1.6M USD | −16.1% reduced | Q2 2022 6 quarters |
| Petco Health & Wellness Co I | < 0.1% | 361,000 | 1.5M USD | −74.2% reduced | Q1 2023 3 quarters |
| Meritage Homes Corp | < 0.1% | 11,814 | 1.4M USD | −92.5% reduced | Q1 2023 3 quarters |
| Installed Bldg Prods Inc | < 0.1% | 10,913 | 1.4M USD | −37.3% reduced | Q4 2022 4 quarters |
| Agree Rlty Corp | < 0.1% | 24,507 | 1.4M USD | −91.8% reduced | Q4 2021 8 quarters |
| ING Groep N.v. | < 0.1% | 101,600 | 1.3M USD | −78.7% reduced | Q2 2023 2 quarters |
| BLK BlackRock | < 0.1% | 2,046 | 1.3M USD | −96.5% reduced | Q4 2022 4 quarters |
| Portillos Inc | < 0.1% | 85,094 | 1.3M USD | −91.9% reduced | Q4 2022 4 quarters |
| Exscientia PLC | < 0.1% | 283,100 | 1.3M USD | −51.1% reduced | Q2 2023 2 quarters |
| The Lion Electric Company | < 0.1% | 655,400 | 1.3M USD | −37.6% reduced | Q4 2022 4 quarters |
| Halozyme Therapeutics Inc | < 0.1% | 32,160 | 1.2M USD | −91.5% reduced | Q3 2022 5 quarters |
| Zynex Inc | < 0.1% | 147,409 | 1.2M USD | −52.6% reduced | Q1 2023 3 quarters |
| Morphosys AG | < 0.1% | 174,818 | 1.2M USD | −20.1% reduced | Q2 2023 2 quarters |
| Oatly Group AB | < 0.1% | 1,232,500 | 1.1M USD | −53.6% reduced | Q1 2023 3 quarters |
| Ftc Solar Inc | < 0.1% | 840,000 | 1.1M USD | −61.5% reduced | Q1 2023 3 quarters |
| Acadia Pharmaceuticals Inc | < 0.1% | 50,643 | 1.1M USD | −94.3% reduced | Q4 2022 4 quarters |
| NUE Nucor | < 0.1% | 6,738 | 1.1M USD | −86.2% reduced | Q1 2023 3 quarters |
| Guidewire Software Inc | < 0.1% | 11,500 | 1.0M USD | −41.9% reduced | Q1 2023 3 quarters |
| VLO Valero Energy | < 0.1% | 7,062 | 1.0M USD | −97.3% reduced | Q2 2023 2 quarters |
| Privia Health Group Inc | < 0.1% | 43,387 | 997.9K USD | −93.1% reduced | Q4 2022 4 quarters |
| Cano Health Inc | < 0.1% | 3,900,000 | 989.0K USD | −40.5% reduced | Q1 2022 7 quarters |
| ELV Elevance Health | < 0.1% | 2,204 | 959.7K USD | −74.8% reduced | Q4 2022 4 quarters |
| PG Procter & Gamble | < 0.1% | 6,579 | 959.6K USD | −99.0% reduced | Q4 2022 4 quarters |
| Guess Inc | < 0.1% | 44,176 | 956.0K USD | −21.1% reduced | Q4 2022 4 quarters |
| Icosavax Inc | < 0.1% | 123,200 | 954.8K USD | −1.0% reduced | Q1 2023 3 quarters |
| Spirit Aerosystems HLDGS Inc | < 0.1% | 58,959 | 951.6K USD | −74.6% reduced | Q2 2023 2 quarters |
| NFLX Netflix | < 0.1% | 2,484 | 938.0K USD | −96.1% reduced | Q4 2022 4 quarters |
| Frontdoor Inc | < 0.1% | 30,330 | 927.8K USD | −95.0% reduced | Q1 2023 3 quarters |
| MPC Marathon Petroleum | < 0.1% | 5,869 | 888.2K USD | −99.5% reduced | Q4 2022 4 quarters |
| Tegna Inc | < 0.1% | 60,602 | 883.0K USD | −59.6% reduced | Q1 2023 3 quarters |
| Fmc Corp | < 0.1% | 13,100 | 877.3K USD | −59.1% reduced | Q2 2023 2 quarters |
| Atara Biotherapeutics Inc | < 0.1% | 555,000 | 821.4K USD | −3.0% reduced | Q1 2023 3 quarters |
| Tootsie Roll Inds Inc | < 0.1% | 26,047 | 777.8K USD | −12.4% reduced | Q1 2023 3 quarters |
| Bread Financial Holdings Inc | < 0.1% | 22,736 | 777.6K USD | −96.5% reduced | Q4 2018 20 quarters |
| Gds HLDGS Ltd | < 0.1% | 66,113 | 723.9K USD | −80.3% reduced | Q1 2023 3 quarters |
| Hawaiian Elec Industries | < 0.1% | 54,945 | 676.4K USD | −53.2% reduced | Q1 2022 7 quarters |
| Pnm Res Inc | < 0.1% | 15,000 | 669.2K USD | −88.1% reduced | Q2 2023 2 quarters |
| TJX TJX Companies | < 0.1% | 6,783 | 602.9K USD | −98.4% reduced | Q1 2023 3 quarters |
| BKR Baker Hughes | < 0.1% | 16,730 | 590.9K USD | −99.7% reduced | Q3 2022 5 quarters |
| CMCSA Comcast | < 0.1% | 13,313 | 590.3K USD | −12.4% reduced | Q1 2023 3 quarters |
| LMT Lockheed Martin | < 0.1% | 1,373 | 561.5K USD | −98.4% reduced | Q1 2023 3 quarters |
| SPDR Ser TR | < 0.1% | 9,750 | 511.9K USD | −95.0% reduced | Q2 2023 2 quarters |
| Spectrum Brands HLDGS Inc Ne | < 0.1% | 6,518 | 510.7K USD | −98.6% reduced | Q1 2023 3 quarters |
| ES Eversource Energy | < 0.1% | 8,633 | 502.0K USD | −84.6% reduced | Q2 2023 2 quarters |
| Nlight Inc | < 0.1% | 48,000 | 499.2K USD | −83.8% reduced | Q4 2022 4 quarters |
| ADM Archer Daniels Midland | < 0.1% | 6,570 | 495.5K USD | −79.8% reduced | Q2 2022 6 quarters |
| Nordstrom Inc | < 0.1% | 32,754 | 489.3K USD | −89.8% reduced | Q1 2023 3 quarters |
| UHS Universal Health Services | < 0.1% | 3,869 | 486.4K USD | −98.8% reduced | Q4 2022 4 quarters |
| CAH Cardinal Health | < 0.1% | 5,351 | 464.6K USD | −99.4% reduced | Q1 2023 3 quarters |
| Crocs Inc | < 0.1% | 5,235 | 461.9K USD | −99.0% reduced | Q2 2023 2 quarters |
| Builders Firstsource Inc | < 0.1% | 3,671 | 457.0K USD | −71.0% reduced | Q1 2023 3 quarters |
| GEN Gen Digital | < 0.1% | 25,300 | 447.3K USD | −96.3% reduced | Q1 2023 3 quarters |
| ENPH Enphase Energy | < 0.1% | 3,705 | 445.2K USD | −39.7% reduced | Q2 2023 2 quarters |
| Y-Mabs Therapeutics Inc | < 0.1% | 79,600 | 433.8K USD | −79.2% reduced | Q4 2022 4 quarters |
| Erie Indty Co | < 0.1% | 1,476 | 433.6K USD | −91.0% reduced | Q2 2023 2 quarters |
| ROST Ross Stores | < 0.1% | 3,578 | 404.1K USD | −92.2% reduced | Q4 2021 8 quarters |
| CL Colgate-Palmolive | < 0.1% | 5,607 | 398.7K USD | −97.6% reduced | Q2 2022 6 quarters |
| Smucker J M Co | < 0.1% | 3,100 | 381.0K USD | −89.4% reduced | Q3 2022 5 quarters |
| Equitable HLDGS Inc | < 0.1% | 13,150 | 373.3K USD | −95.6% reduced | Q1 2020 15 quarters |
| Diamond Offshore Drilling In | < 0.1% | 24,800 | 364.1K USD | −92.6% reduced | Q1 2023 3 quarters |
| Vincerx Pharma Inc | < 0.1% | 344,827 | 348.3K USD | 0.0% reduced | Q3 2021 9 quarters |
| Amerisafe Inc | < 0.1% | 6,647 | 332.8K USD | −83.9% reduced | Q4 2022 4 quarters |
| Select Sector SPDR TR | < 0.1% | 2,000 | 322.0K USD | −95.1% reduced | Q1 2023 3 quarters |
| MCO Moody's Corporation | < 0.1% | 983 | 310.8K USD | −98.0% reduced | Q2 2023 2 quarters |
| Pvh Corporation | < 0.1% | 4,011 | 306.9K USD | −99.2% reduced | Q4 2020 12 quarters |
| Old Rep Intl Corp | < 0.1% | 11,372 | 306.4K USD | −95.0% reduced | Q4 2022 4 quarters |
| Caci Intl Inc | < 0.1% | 966 | 303.2K USD | −99.3% reduced | Q3 2020 13 quarters |
| Mbia Inc | < 0.1% | 40,900 | 294.9K USD | −71.9% reduced | Q4 2022 4 quarters |
| Hess Corp | < 0.1% | 1,810 | 276.9K USD | −97.1% reduced | Q2 2023 2 quarters |
| Uniqure NV | < 0.1% | 40,975 | 274.9K USD | −86.9% reduced | Q2 2020 14 quarters |
| Iridium Communications Inc | < 0.1% | 5,615 | 255.4K USD | −31.0% reduced | Q2 2023 2 quarters |
| IR Ingersoll Rand | < 0.1% | 3,816 | 243.2K USD | −98.8% reduced | Q2 2023 2 quarters |
| United Therapeutics Corp Del | < 0.1% | 1,037 | 234.2K USD | −91.3% reduced | Q2 2023 2 quarters |
| EOG EOG Resources | < 0.1% | 1,845 | 233.9K USD | −69.4% reduced | Q2 2023 2 quarters |
| Splunk Inc | < 0.1% | 1,592 | 232.9K USD | −60.5% reduced | Q1 2021 11 quarters |
| CINF Cincinnati Financial | < 0.1% | 2,166 | 221.6K USD | −97.4% reduced | Q1 2023 3 quarters |
| Itt Inc | < 0.1% | 2,257 | 221.0K USD | −98.5% reduced | Q4 2022 4 quarters |
| Voya Financial Inc | < 0.1% | 3,140 | 208.6K USD | −98.9% reduced | Q1 2023 3 quarters |
| GL Globe Life | < 0.1% | 1,765 | 191.9K USD | −97.9% reduced | Q2 2023 2 quarters |
| Novocure Ltd | < 0.1% | 11,544 | 186.4K USD | −53.5% reduced | Q2 2023 2 quarters |
| Forward Air Corp | < 0.1% | 2,547 | 175.1K USD | −90.9% reduced | Q2 2023 2 quarters |
| Buckle Inc | < 0.1% | 5,158 | 172.2K USD | −70.5% reduced | Q2 2023 2 quarters |
| Relay Therapeutics Inc | < 0.1% | 20,215 | 170.0K USD | −92.7% reduced | Q2 2023 2 quarters |
| Oceaneering Intl Inc | < 0.1% | 6,541 | 168.2K USD | −93.9% reduced | Q2 2023 2 quarters |
| DVA DaVita | < 0.1% | 1,716 | 162.2K USD | −98.4% reduced | Q3 2022 5 quarters |
| Employers HLDGS Inc | < 0.1% | 3,987 | 159.3K USD | −71.3% reduced | Q2 2023 2 quarters |
| Visteon Corp | < 0.1% | 1,136 | 156.8K USD | −99.0% reduced | Q1 2023 3 quarters |
| Driven Brands HLDGS Inc | < 0.1% | 12,400 | 156.1K USD | −98.4% reduced | Q2 2022 6 quarters |
| Huntsman Corp | < 0.1% | 6,356 | 155.1K USD | −68.7% reduced | Q1 2023 3 quarters |
| Brighthouse Finl Inc | < 0.1% | 3,134 | 153.4K USD | −95.7% reduced | Q2 2022 6 quarters |
| WRB W. R. Berkley Corporation | < 0.1% | 2,265 | 143.8K USD | −99.6% reduced | Q2 2020 14 quarters |
| Rlx Technology Inc | < 0.1% | 94,600 | 142.8K USD | −93.0% reduced | Q1 2023 3 quarters |
| Mynaric AG | < 0.1% | 29,665 | 142.4K USD | −27.9% reduced | Q4 2021 8 quarters |
| The Odp Corp | < 0.1% | 3,078 | 142.1K USD | −12.1% reduced | Q1 2023 3 quarters |
| Zura Bio Ltd | < 0.1% | 21,100 | 139.3K USD | −95.5% reduced | Q2 2023 2 quarters |
| Bridgebio Pharma Inc | < 0.1% | 5,265 | 138.8K USD | −92.1% reduced | Q1 2023 3 quarters |
| Texas Pacific Land Corporati | < 0.1% | 74 | 134.9K USD | −74.5% reduced | Q2 2023 2 quarters |
| Wex Inc | < 0.1% | 717 | 134.9K USD | −74.1% reduced | Q1 2023 3 quarters |
| Archrock Inc | < 0.1% | 10,254 | 129.2K USD | −96.5% reduced | Q2 2023 2 quarters |
| Travere Therapeutics Inc | < 0.1% | 13,572 | 121.3K USD | −99.2% reduced | Q2 2023 2 quarters |
| Rackspace Technology Inc | < 0.1% | 50,303 | 118.2K USD | −25.2% reduced | Q1 2023 3 quarters |
| Helix Energy Solutions Grp I | < 0.1% | 10,520 | 117.5K USD | −98.8% reduced | Q3 2022 5 quarters |
| Harley Davidson Inc | < 0.1% | 3,489 | 115.4K USD | −98.7% reduced | Q1 2023 3 quarters |
| TMO Thermo Fisher Scientific | < 0.1% | 219 | 110.8K USD | −86.3% reduced | Q2 2023 2 quarters |
| CIEN Ciena | < 0.1% | 2,329 | 110.1K USD | −97.6% reduced | Q1 2023 3 quarters |
| Maxcyte Inc | < 0.1% | 33,200 | 103.6K USD | −67.1% reduced | Q3 2022 5 quarters |
| Par Pac Holdings Inc | < 0.1% | 2,850 | 102.4K USD | −98.4% reduced | Q1 2023 3 quarters |
| Moog Inc | < 0.1% | 822 | 92.9K USD | −98.3% reduced | Q2 2023 2 quarters |
| Gracell Biotechnologies Inc | < 0.1% | 31,200 | 89.9K USD | −96.9% reduced | Q2 2023 2 quarters |
| Luminar Technologies Inc | < 0.1% | 19,000 | 86.5K USD | −94.6% reduced | Q3 2022 5 quarters |
| Chefs Whse Inc | < 0.1% | 4,079 | 86.4K USD | −99.5% reduced | Q2 2022 6 quarters |
| RSG Republic Services | < 0.1% | 596 | 84.9K USD | −98.9% reduced | Q2 2022 6 quarters |
| Shake Shack Inc | < 0.1% | 1,402 | 81.4K USD | −93.9% reduced | Q2 2023 2 quarters |
| Sabre Corp | < 0.1% | 17,900 | 80.4K USD | −99.3% reduced | Q1 2023 3 quarters |
| Arcus Biosciences Inc | < 0.1% | 4,457 | 80.0K USD | −99.4% reduced | Q2 2023 2 quarters |
| Smart Global HLDGS Inc | < 0.1% | 3,200 | 77.9K USD | −22.2% reduced | Q1 2023 3 quarters |
| BEN Franklin Resources | < 0.1% | 3,165 | 77.8K USD | −99.4% reduced | Q1 2023 3 quarters |
| Schrodinger Inc | < 0.1% | 2,692 | 76.1K USD | −53.5% reduced | Q4 2022 4 quarters |
| N-Able Inc | < 0.1% | 5,500 | 71.0K USD | −14.6% reduced | Q2 2023 2 quarters |
| Outfront Media Inc | < 0.1% | 6,921 | 69.9K USD | −99.2% reduced | Q1 2023 3 quarters |
| MGM MGM Resorts | < 0.1% | 1,873 | 68.8K USD | −33.0% reduced | Q1 2023 3 quarters |
| Westrock Co | < 0.1% | 1,649 | 59.0K USD | −98.7% reduced | Q3 2022 5 quarters |
| Quinstreet Inc | < 0.1% | 6,500 | 58.3K USD | −94.7% reduced | Q2 2023 2 quarters |
| Taboola.com Ltd | < 0.1% | 14,446 | 54.8K USD | −42.8% reduced | Q1 2023 3 quarters |
| AOS A. O. Smith | < 0.1% | 813 | 53.8K USD | −66.4% reduced | Q4 2022 4 quarters |
| Aar Corp | < 0.1% | 777 | 46.3K USD | −13.7% reduced | Q2 2023 2 quarters |
| SNA Snap-on | < 0.1% | 180 | 45.9K USD | −15.1% reduced | Q1 2023 3 quarters |
| SIRI Sirius XM | < 0.1% | 10,000 | 45.2K USD | −99.7% reduced | Q1 2023 3 quarters |
| TXT Textron | < 0.1% | 518 | 40.5K USD | −78.0% reduced | Q2 2023 2 quarters |
| Hanover Ins Group Inc | < 0.1% | 356 | 39.5K USD | −99.6% reduced | Q1 2023 3 quarters |
| Blue Bird Corp | < 0.1% | 1,800 | 38.4K USD | −47.5% reduced | Q2 2023 2 quarters |
| PPG PPG Industries | < 0.1% | 283 | 36.7K USD | −22.3% reduced | Q2 2023 2 quarters |
| Veritiv Corp | < 0.1% | 200 | 33.7K USD | −36.5% reduced | Q1 2023 3 quarters |
| Federal Rlty Invt TR New | < 0.1% | 359 | 32.5K USD | −98.8% reduced | Q1 2023 3 quarters |
| Blend Labs Inc | < 0.1% | 23,176 | 31.8K USD | −50.6% reduced | Q2 2023 2 quarters |
| Corvel Corp | < 0.1% | 159 | 31.3K USD | −51.4% reduced | Q1 2023 3 quarters |
| Healthcare Svcs Group Inc | < 0.1% | 2,995 | 31.2K USD | −20.9% reduced | Q1 2023 3 quarters |
| IP International Paper | < 0.1% | 868 | 30.8K USD | −73.4% reduced | Q2 2023 2 quarters |
| Vir Biotechnology Inc | < 0.1% | 3,100 | 29.0K USD | −99.4% reduced | Q1 2023 3 quarters |
| Vnet Group Inc | < 0.1% | 9,141 | 28.6K USD | −94.9% reduced | Q2 2023 2 quarters |
| LYV Live Nation Entertainment | < 0.1% | 340 | 28.2K USD | −99.9% reduced | Q4 2022 4 quarters |
| Coherus Biosciences Inc | < 0.1% | 7,491 | 28.0K USD | −99.2% reduced | Q2 2023 2 quarters |
| Varonis Sys Inc | < 0.1% | 900 | 27.5K USD | −18.6% reduced | Q1 2023 3 quarters |
| Dmc Global Inc | < 0.1% | 1,000 | 24.5K USD | −58.4% reduced | Q1 2023 3 quarters |
| Medifast Inc | < 0.1% | 299 | 22.4K USD | −99.4% reduced | Q1 2023 3 quarters |
| Arrowhead Pharmaceuticals In | < 0.1% | 811 | 21.8K USD | −10.7% reduced | Q2 2023 2 quarters |
| Tetra Technologies Inc Del | < 0.1% | 3,186 | 20.3K USD | −99.7% reduced | Q2 2023 2 quarters |
| Chegg Inc | < 0.1% | 2,095 | 18.7K USD | −26.1% reduced | Q2 2023 2 quarters |
| Editas Medicine Inc | < 0.1% | 2,200 | 17.2K USD | −28.5% reduced | Q1 2023 3 quarters |
| Motorcar Pts Amer Inc | < 0.1% | 1,957 | 15.8K USD | −66.4% reduced | Q1 2023 3 quarters |
| The Realreal Inc | < 0.1% | 6,598 | 13.9K USD | −9.8% reduced | Q2 2023 2 quarters |
| Ocugen Inc | < 0.1% | 34,341 | 13.7K USD | −59.1% reduced | Q1 2023 3 quarters |
| Vaxart Inc | < 0.1% | 18,118 | 13.7K USD | −7.8% reduced | Q1 2023 3 quarters |
| Universal Electrs Inc | < 0.1% | 1,449 | 13.1K USD | −63.8% reduced | Q1 2023 3 quarters |
| Inotiv Inc | < 0.1% | 3,824 | 11.8K USD | −1.4% reduced | Q1 2023 3 quarters |
| Baozun Inc | < 0.1% | 3,363 | 10.4K USD | −51.4% reduced | Q2 2023 2 quarters |
| Bumble Inc | < 0.1% | 666 | 9.9K USD | −99.9% reduced | Q3 2022 5 quarters |
| Varex Imaging Corp | < 0.1% | 492 | 9.2K USD | −23.4% reduced | Q2 2023 2 quarters |
| Gannett Co Inc | < 0.1% | 3,400 | 8.3K USD | −92.8% reduced | Q1 2023 3 quarters |
| Bioxcel Therapeutics Inc | < 0.1% | 2,669 | 6.8K USD | −98.9% reduced | Q2 2023 2 quarters |
| Nutex Health Inc | < 0.1% | 22,000 | 4.5K USD | −89.7% reduced | Q1 2023 3 quarters |
| Multiplan Corporation | < 0.1% | 2,400 | 4.0K USD | −99.1% reduced | Q1 2023 3 quarters |
| Cullinan Oncology Inc | < 0.1% | 224 | 2.0K USD | −88.9% reduced | Q2 2023 2 quarters |
| Amylyx Pharmaceuticals Inc | < 0.1% | 46 | 842.0 USD | −99.4% reduced | Q2 2022 6 quarters |
| ZTO ZTO Express | < 0.1% | 28 | 677.0 USD | −100.0% reduced | Q2 2023 2 quarters |
| Dada Nexus Ltd | < 0.1% | 84 | 374.0 USD | −99.5% reduced | Q2 2023 2 quarters |
| Cara Therapeutics Inc | < 0.1% | 116 | 195.0 USD | −98.4% reduced | Q1 2023 3 quarters |
| Atricure Inc | < 0.1% | 4 | 175.0 USD | −100.0% reduced | Q1 2023 3 quarters |
| Emeren Group Ltd | < 0.1% | 54 | 166.0 USD | −98.7% reduced | Q2 2023 2 quarters |
| Cryoport Inc | < 0.1% | 10 | 137.0 USD | −98.6% reduced | Q2 2023 2 quarters |
| Sharecare Inc | < 0.1% | 112 | 105.0 USD | −100.0% reduced | Q3 2021 9 quarters |
| Agilysys Inc | < 0.1% | 1 | 66.0 USD | −94.7% reduced | Q2 2023 2 quarters |
| Shutterstock Inc | < 0.1% | 1 | 38.0 USD | −93.8% reduced | Q1 2023 3 quarters |
| Domo Inc | < 0.1% | 3 | 30.0 USD | −99.9% reduced | Q1 2023 3 quarters |
| Lendingtree Inc New | < 0.1% | 1 | 15.0 USD | −99.9% reduced | Q2 2023 2 quarters |
| Stitch Fix Inc | < 0.1% | 3 | 10.0 USD | −99.9% reduced | Q2 2023 2 quarters |
| Chindata Group HLDGS Ltd | < 0.1% | 1 | 8.0 USD | −100.0% reduced | Q2 2022 6 quarters |
| Douglas Elliman Inc | < 0.1% | 3 | 7.0 USD | −100.0% reduced | Q1 2023 3 quarters |
| American Pub Ed Inc | < 0.1% | 1 | 5.0 USD | −99.9% reduced | Q1 2023 3 quarters |
| Granite Pt Mtg TR Inc | < 0.1% | 1 | 3.0 USD | −100.0% reduced | Q1 2023 3 quarters |
| Design Therapeutics Inc | < 0.1% | 1 | 2.0 USD | −100.0% reduced | Q1 2023 3 quarters |
| Kinnate Biopharma Inc | < 0.1% | 1 | 1.0 USD | −100.0% reduced | Q2 2023 2 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Plus 687 option positions, value of the underlying shares as reported 4.9B USD – not included in the weights.
The filing states the value of the shares the options refer to. Whether a put is a hedge or a bet on falling prices is not stated in the filing.
- SPDR S&P 500 ETF TR Put 996.4M USD
- SPDR S&P 500 ETF TR Call 420.7M USD
- Lowe's Put 159.4M USD
- Nvidia Call 84.8M USD
- Novo Nordisk (ADR) Put 80.0M USD
- Ishares TR Call 79.6M USD
- SPDR Ser TR Put 68.9M USD
- SPDR Ser TR Put 59.2M USD
- Invesco QQQ TR Put 58.9M USD
- Exelixis Inc Call 56.7M USD
Plus 45 positions in convertible bonds and bonds worth 436.0M USD as reported – not included in the weights.
Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.
- Wayfair Inc principal 36.6M USD 30.1M USD
- Ascendis Pharma A/S principal 29.0M USD 26.6M USD
- Cytokinetics Inc principal 23.0M USD 19.6M USD
- Lyft Inc principal 18.8M USD 17.3M USD
- Wayfair Inc principal 19.0M USD 16.5M USD
- Sarepta Therapeutics Inc principal 9.0M USD 15.9M USD
- Unity Software Inc principal 20.0M USD 15.9M USD
- Liveperson Inc principal 16.0M USD 15.6M USD
- Guardant Health Inc principal 21.5M USD 14.9M USD
- Bridgebio Pharma Inc principal 14.5M USD 13.9M USD
Breakdown by sector
- Technology 13.4%
- Consumer Discretionary 6.9%
- Industrials 6.6%
- Health Care 6.6%
- Financials 4.1%
- Utilities 3.8%
- Communication Services 3.7%
- Consumer Staples 3.7%
- Materials 2.5%
- Energy 2.0%
- Real Estate 1.2%
- not in our coverage 45.5%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors